Dr. Milton D Soderberg, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1414 W Fair Ave Ste 240, Marquette, MI 49855 Phone: 906-225-3939 Fax: 906-225-7488 |
Dr. Natalie Pianetto Walker, DNP, FNP-BC Dermatology Medicare: Medicare Enrolled Practice Location: 1009 W Ridge St Ste C, Marquette, MI 49855 Phone: 906-228-6545 Fax: 906-228-8236 |
Dennis A Herzog, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1414 W Fair Ave, Suite 240, Marquette, MI 49855 Phone: 906-225-3970 |
Dr. Jordan Brooks, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1007 Harbor Hills Dr Ste C, Marquette, MI 49855 Phone: 906-225-5458 Fax: 906-225-1179 |
News Archive
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it held a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of Montelukast Sodium Oral Soluble Film (OSF) under a 505(b)(2) pathway.
The Wall Street Journal reports that Medicare could save $500 million a year by switching from one type of eye medicine to another, both made by Genentech, "according to a draft study by federal officials and a University of Miami eye doctor.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.
Researchers have successfully transplanted bioengineered lungs into pigs, without any complications arising.
A new study from the Howard Florey Institute in Melbourne may help explain why people who experimented with amphetamines, such as 'speed', as teenagers are more likely to become addicted and more susceptible to heart attack following re-use of the drug as adults.
› Verified 7 days ago